Neill Walsdorf, Sr., Chairman of the Board at Mission Pharmacal Company, followed in the footsteps of his father, third-generation pharmacist H.N. Walsdorf, who founded Mission in 1946. Neill Walsdorf joined Mission in 1959, serving in various sales and marketing positions before assuming the roles of President and Chief Executive Officer.
In his earlier roles, Walsdorf directed product development. When he was diagnosed with kidney stone disease in the early 1980s, he quickly discovered that existing treatment options were limited. Walsdorf’s passion for developing much-needed therapies in this area grew strong. Mission funded The Neill Walsdorf Sr. Biotechnology Center in Mineral Metabolism at the University of Texas Southwestern Medical Center to help produce leading drugs and devices to diagnose, treat, and prevent urological conditions.
Walsdorf is a member of the Buck Advisory Council of the Buck Institute for Research on Aging, along with his son Neill Walsdorf, Jr., and is a board member of the Mineral Metabolism Foundation. He is also a member of the Advisory Council at the College of Liberal and Fine Arts at the University of Texas and serves on the Texas Pharmaceutical Advisory Council at the College of Pharmacy at the University of Texas.
In addition to his passion for education and delivering high-quality healthcare solutions, he enjoys playing jazz and tennis, spending time with his family in San Antonio, and competitive sailing.
